Search Results - Alex Bataller
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development by Lorena Pérez-Amill, Lorena Pérez-Amill, Lorena Pérez-Amill, Àlex Bataller, Àlex Bataller, Julio Delgado, Julio Delgado, Julio Delgado, Jordi Esteve, Jordi Esteve, Jordi Esteve, Manel Juan, Manel Juan, Manel Juan, Manel Juan, Nela Klein-González, Nela Klein-González, Nela Klein-González
Published in Frontiers in Immunology (2023-11-01)Get full text
Article -
3
P743: CLINICAL OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SPLICEOSOME MUTATIONS by Samuel Urrutia, Emmanuel Almanza, Alex Bataller, Koji Sasaki, Kelly Chien, Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Carlos Bueso-Ramos, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article -
4
PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes by Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Kelly Chien, Koji Sasaki, Wei Ying Jen, Mahesh Swaminathan, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian
Published in Haematologica (2025-07-01)Get full text
Article -
5
P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMET... by Carlos Jimenez-Vicente, Francesca Guijarro, Monica Lopez-Guerra, Ares Guardia-Torrelles, Alexandra Martínez Roca, Alex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Dolors Colomer, Marina Diaz-Beya, Jordi Esteve
Published in HemaSphere (2023-08-01)Get full text
Article -
6
Myeloid lineage switch in <i>KMT2A-</i>rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies by Alex Bataller, Tareq Abuasab, David McCall, Wei Wang, Branko Cuglievan, Ghayas C. Issa, Elias Jabbour, Nicholas Short, Courtney D. DiNardo, Guilin Tang, Guillermo Garcia-Manero, Hagop M. Kantarjian, Koji Sasaki
Published in Haematologica (2023-08-01)Get full text
Article -
7
PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS by Ares Guardia-Torrelles, Carlos Jimenez-Vicente, Alexandra Martínez Roca, Sandra Castaño-Díez, Helena Brillembourg, Francesca Guijarro, Àlex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Marina Diaz-Beya, Jordi Esteve, Beatriz Merchan
Published in HemaSphere (2023-08-01)Get full text
Article -
8
P728: EVALUATION OF IPSS-M IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SPLICEOSOME MUTATIONS by Samuel Urrutia, Ziyi LI, Emmanuel Almanza, Alex Bataller, Rashmi Kanagal-Shamanna, Jayastu Senapati, Koji Sasaki, Kelly Chien, Guillermo Montalban-Bravo, Courtney Dinardo, Gautam Borthakur, Carlos Bueso Ramos, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article -
9
P500: SUPERIOR OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AMONG PATIENTS ≥ 60 YEARS TREATED WITH CLADRIBINE, LOW DOSE CYTARABINE PLUS VENETOCLAX FOR NEWLY DIAGNOSED ACUTE... by Jayastu Senapati, Hagop Kantarjian, Alexandre Bazinet, Patrick Reville, Gautam Borthakur, Naval Daver, Courtney Dinardo, Alex Bataller, Elias Jabbour, Nicholas Short, Uday R. Popat, Amin Majid Alousi, Elizabeth J. Shpall, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia
Published in HemaSphere (2023-08-01)Get full text
Article -
10
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact by Pablo Mozas, Juan A. Pineyroa, Ferran Nadeu, Laura Magnano, Andrea Rivero, Alfredo Rivas-Delgado, Alex Bataller, Aleix Fabregat, Eva Gine, Tycho Baumann, Neus Villamor, Juan Ignacio Arostegui, Marta Aymerich, Armando Lopez-Guillermo, Elias Campo, Julio Delgado
Published in Haematologica (2020-11-01)Get full text
Article -
11
S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA by Alex Bataller, Alexandre Bazinet, Sangeetha Venugopal, Guillermo Montalban-Bravo, Yesid Alvarado, Kelly Chien, Ghayas Issa, Nicholas Short, Danielle Hammond, Lucia Masarova, Tapan Kadia, Rashmi Kanagal-Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop Kantarjian, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article -
12
P748: IPSS-M PERFORMANCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT THE TIME OF HYPOMETHYLATING AGENT FAILURE by Samuel Urrutia, Kelly Chien, Ziyi LI, Alex Bataller, Emmanuel Almanza, Koji Sasaki, Guillermo Montalban-Bravo, Nicholas Short, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Gautam Borthakur, Rashmi Kanagal-Shamanna, Carlos Bueso Ramos, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article -
13
P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE by Kelly Chien, Samuel Urrutia, Ziyi LI, Rashmi Kanagal-Shamanna, Emmanuel Almanza, Tareq Abuasab, Georgina Gener, Alex Bataller, Alexandre Bazinet, Guillermo Montalban-Bravo, Nicholas Short, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Gautam Borthakur, Danielle Hammond, Mahesh Swaminathan, Koji Sasaki, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Published in HemaSphere (2023-08-01)Get full text
Article -
14
A Phase 2 study of CPX‐351 in combination with venetoclax in patients with newly diagnosed high‐risk acute myeloid leukemia by Wei‐Ying Jen, Jennifer Croden, Emmanuel Almanza‐Huante, Courtney DiNardo, Kelly Chien, Danielle Hammond, Wei Qiao, Yesid Alvarado, Lucia Masarova, Andres E. Quesada, Sherry Pierce, Alex Bataller, Guillermo Garcia‐Manero, Amin Alousi, Nicholas Short, Naval Daver, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia
Published in HemaSphere (2025-10-01)Get full text
Article -
15
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy by Wei-Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short
Published in Blood Advances (2025-02-01)Get full text
Article -
16
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort by Guadalupe Oñate, Marta Pratcorona, Ana Garrido, Alicia Artigas-Baleri, Alex Bataller, Mar Tormo, Montserrat Arnan, Susana Vives, Rosa Coll, Olga Salamero, Ferran Vall-Llovera, Antònia Sampol, Antoni Garcia, Marta Cervera, Sara Garcia Avila, Joan Bargay, Xavier Ortín, Josep F. Nomdedéu, Jordi Esteve, Jorge Sierra, Spanish Cooperative Group for the Study and Treatment of Acute Leukemias and Myelodysplasias (CETLAM)
Published in Blood Cancer Journal (2023-05-01)Get full text
Article -
17
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse by Alex Bataller, Hagop Kantarjian, Alexandre Bazinet, Tapan Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Keyur Patel, Guilin Tang, Koji Sasaki, Nicholas J. Short, Musa Yilmaz, Ghayas C. Issa, Yesid Alvarado, Guillermo Montalban-Bravo, Abhishek Maiti, Hussein A. Abbas, Koichi Takahashi, Sherry Pierce, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi
Published in Haematologica (2024-05-01)Get full text
Article -
18
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo by Pablo Menendez, Maria Castella, Pedro Marín, Alex Bataller, Jordi Esteve, Diego Sánchez Martínez, Francisco Gutiérrez Agüera, Heleia Roca Ho, Clara Bueno, Matteo Libero Baroni, Talia Velasco Hernandez, Rafael Diaz de la Guardia, Julio Castaño, Eduardo Anguita, Susana Vives, Josep Nomdedeu, Helene Lapillone, Anne E Bras, Vincent H J van der Velden, Jordi Junca, Binje Vick, Irmela Jeremias, Angel Lopez, Marc Sorigue
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
19
Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients by Christophe Willekens, Alexandre Bazinet, Samy Chraibi, Alex Bataller, Justine Decroocq, Naszrin Arani, Benjamin Carpentier, Caitlin Rausch, Delphine Lebon, Abhishek Maiti, Nicolas Gauthier, Nicholas Short, Sarah Bonnet, Koji Sasaki, Sabine Khalife-Hachem, Mahesh Swaminathan, Jean-Baptiste Micol, Florence Pasquier, Christophe Marzac, Damien Roos-Weil, Laurent Pascal, Naval Daver, Tapan Kadia, Didier Bouscary, Farhad Ravandi, Arnaud Pages, Hagop Kantarjian, Stéphane De Botton, Courtney DiNardo
Published in Blood Cancer Journal (2025-04-01)Get full text
Article -
20
P1356: CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES by Lorenza Pérez Amill, Mercedes Armand Ugon, Sergio Peña Pérez, Maria Val Casals, Claudio Santos, Gerard Frigola, José Ramon Álamo, Francesca Guijarro, Alfredo Minguela, Àlex Bataller, Juan Gonzalo Correa Saldarriaga, Berta Casanovas Albertí, Mireia Uribe Herranz, Europa Azucena Gonzalez, Daniel Benitez-Ribas, Diego Sanchez, Nestor Tirado, Paola Romecin, Talía Velasco, Pablo Menendez, Antonio Martínez, Montserrat Rovira Tarrats, Jordi Esteve, Avaro Urbano Ispizua, Julio Delgado, Manel Juan, Nela Klein González
Published in HemaSphere (2023-08-01)Get full text
Article
